Backbone amide linker (BAL) strategy for Nα-9-fluorenylmethoxycarbonyl (Fmoc) solid-phase synthesis of peptide aldehydes

Journal of Peptide Science

Volumn 11, Issue 9, 2005, Pages 525-535

  Kappel, Joseph C ^a   Barany, George ^a  

^a University of Minnesota   (United States)

Author keywords

1,3 dioxolanes; Backbone amide linker (BAL); Dimethyl acetals; Peptide aldehydes; Protease inhibitors; Solid phase synthesis

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 9 FLUORENYLMETHYL CHLOROFORMATE; ALDEHYDE DERIVATIVE; AMIDE; ANTIPAIN; CALPAIN; CALPEPTIN; CATHEPSIN B; CHYMOSTATIN; CHYMOTRYPSIN; CVS 1123; CYSTEINE; EFEGATRAN; ELASTASE; ELASTATINAL; INTERLEUKIN 1BETA CONVERTING ENZYME; KALLIKREIN; L 709049; LEUPEPTIN; LY 338387; MONOMER; PEPTIDE DERIVATIVE; PLASMIN; PROTEIN INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RESIN; THROMBIN; TRYPSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACYLATION; ADULT RESPIRATORY DISTRESS SYNDROME; ALZHEIMER DISEASE; AMINATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATARACT; CHEMICAL PROCEDURES; CONTRACEPTION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; EMPHYSEMA; EPIMERIZATION; HEART INFARCTION; INFLAMMATION; INFLAMMATORY DISEASE; METASTASIS POTENTIAL; MUSCULAR DYSTROPHY; OSTEOLYSIS; PANCREATITIS; PRIORITY JOURNAL; PROTEINASE INHIBITION; RHEUMATOID ARTHRITIS; SOLID PHASE SYNTHESIS; STROKE; STRUCTURE ANALYSIS; THROMBOSIS;

ALDEHYDES; AMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORENES; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

EID: 23944486692     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.614     Document Type: Article

References (77)

1. Guillaumie F, Kelly NM, Kappel JC, Barany G, Jensen KJ. Solid-phase synthesis of peptide aldehydes by a backbone amide linker (BAL) strategy. In Peptides for the New Millennium: Proceedings of the Sixteenth American Peptide Symposium, Fields GB, Tam JP, Barany G (eds). Kluwer: Dordrecht, The Netherlands, 2000; 100-101.
2. Guillaumie F, Kappel JC, Kelly NM, Barany G, Jensen KJ. Solid-phase synthesis of C-terminal peptide aldehydes from amino acetals anchored to a backbone amide linker (BAL) handle. Tetrahedron Lett. 2000; 41: 6131-6135.
3. James MNG, Sielecki AR. Aspartic proteinases and their catalytic pathway. In Biological Macromolecules and Assemblies: Active Sites of Enzymes, vol. 3, Jurnak FA, McPherson A (eds). John Wiley & Sons: New York, 1987; 413-482.
4. Babine RE, Bender SL. Molecular recognition of protein-ligand complexes: Applications to drug design. Chem. Rev. 1997; 97: 1359-1472.
5. Otto HH, Schirmeister T. Cysteine proteases and their inhibitors. Chem. Rev. 1997; 97: 133-171.
6. Leung D, Abbenante G, Fairlie DP. Protease inhibitors: Current status and future prospects. J. Med. Chem. 2000; 43: 305-341.
7. Walker B, Lynas JF. Strategies for the inhibition of serine proteases. Cell. Mol. Life Sci. 2001; 58: 596-624.
8. Craik MS, Debouck C. Proteases as therapeutic targets. In Perspectives in Drug Discovery and Design, vol. 2, James MNG (ed.). ESCOM: Leiden, 1995; 1-125.
9. Aoyagi T, Takeuchi T, Matsuzaki A, Kawamura K, Kondo SI, Hamada M, Maeda K, Umezawa H. Leupeptins, new proteinase inhibitors from actinomycetes. J. Antibiot. 1969; 22: 283-286.
10. Wolfenden R. Analog approaches to the structure of the transition state in enzyme reactions. Acc. Chem. Res. 1972; 5: 10-18.
11. Leinhard GE. Enzymatic catalysis and transition-state theory. Science 1973; 180: 149-154.
12. Thompson RC. Use of peptide aldehydes to generate transition-state analogs of elastase. Biochemistry 1973; 12: 47-51.
13. Schultz RM, Cheerva AC. The binding of a non-specific 'transition state analogue' to α-chymotrypsin. FEBS Lett. 1975; 50: 47-49.
14. Lewis CA, Jr, Wolfenden R. Thiohemiacetal formation by inhibitory aldehydes at the active site of papain. Biochemistry 1977; 16: 4890-4895.
15. Kennedy WP. Schultz RM. Mechanism of association of a specific aldehyde 'transition-state analogue' to the active site of α-chymotrypsin. Biochemistry 1979; 18: 349-356.
16. Gamcsik MP, Malthouse PG, Primrose WU, Mackenzie NE, Boyd ASF, Russell RA, Scott AI. Structure and stereochemistry of tetrahedral inhibitor complexes of papain by direct NMR observation. J. Am. Chem. Soc. 1983; 105: 6324-6325.
17. Sarubbi E, Seneci PF, Angelastro MR, Peet NP, Denaro M, Islam K. Peptide aldehydes as inhibitors of HIV protease. FEBS Lett. 1993; 319: 253-256.
18. Jurczak J, Golebiowski A. Optically active N-protected α-amino aldehydes in organic synthesis. Chem. Rev. 1989; 89: 149-164.
19. Sardina FJ, Rapoport H. Enantiospecific synthesis of heterocycles from α-amino acids. Chem. Rev. 1996; 96: 1825-1872.
20. Jacobson KA, Marr-Leisy D, Rosenkranz RP, Verlander MS, Melmon KL, Goodman M. Conjugates of catecholamines. 1. N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol. J. Med. Chem. 1983; 26: 492-499.
21. 2NAc peptide bond isosteres on the antagonistic and histamine releasing activities of a luteinizing hormone-releasing hormone analogue. J. Med. Chem. 1988; 31: 1820-1824.
22. Greenlee WJ. Renin inhibitors. J. Med. Res. Rev. 1990; 10: 173-236.
23. Rose K. Facile synthesis of homogeneous artificial proteins. J. Am. Chem. Soc. 1994; 116: 30-33.
24. Canne LE, Ferré-D'Amaré AR, Burley SK, Kent SBH. Total chemical synthesis of a unique transcription factor-related protein: cMyc-Max. J. Am. Chem. Soc. 1995; 117: 2998-3007.
25. King TP, Zhao SW, Lam T. Preparation of protein conjugates via intermolecular hydrazone linkage. Biochemistry 1986; 25: 5774-5779.
26. Liu C-F, Rao C, Tam JP. Orthogonal ligation of unprotected peptide segments through pseudoproline formation for the synthesis of HIV-1 protease analogs. J. Am. Chem. Soc. 1996; 118: 307-312.
27. Dixon HBF, Weitkamp LR. Conversion of the N-terminal serine residue of corticotrophin into glycine. Biochem. J. 1962; 84: 462-468.
28. Zhang L, Torgerson TR, Liu X-Y, Timmons S, Colosia AD, Hawiger J, Tam JP. Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules. Proc. Natl Acad. Sci. USA 1998; 95: 9184-9189.
29. Pallin TD, Tam JP. Cyclization of totally unprotected peptides in aqueous solution by oxime formation. J. Chem. Soc. Chem. Commun. 1995; 19: 2021-2022.
30. Carulla N, Woodward C, Barany G. Toward new designed proteins derived from bovine pancreatic trypsin inhibitor (BPTI): Covalent cross-linking of two 'core modules' by oxime-forming ligation. Bioconjug. Chem. 2001; 12: 726-741.
31. Nahm S, Weinreb SM. N-methoxy-N-methylamides as effective acylating agents. Tetrahedron Lett. 1981; 22: 3815-3818.
32. Fehrentz JA, Paris M, Heitz A, Velek J, Liu CF, Winternitz F, Martinez J. Improved solid phase synthesis of C-terminal peptide aldehydes. Tetrahedron Lett. 1995; 36: 7871-7874.
33. Fehrentz JA, Paris M, Heitz A, Valek J, Winternitz F, Martinez J. Solid phase synthesis of C-terminal peptide aldehydes. J. Org. Chem. 1997; 62: 6792-6796.
34. Tong X-H, Hong A. Solid phase synthesis of aspartyl peptide aldehydes. Tetrahedron Lett. 2000; 41: 8857-8860.
35. Higaki JN, Chakravarty S, Bryant CM, Cowart LR, Harden P, Scardina JM, Mavunkel B, Luedtke GR, Cordell B. A combinatorial approach to the identification of dipeptide aldehyde inhibitors of β-amyloid production. J. Med. Chem. 1999; 42: 3889-3898.
36. Salvino JM, Mervic M, Mason HJ, Kiesow T, Teager D, Airey J, Labaudiniere R. Parallel synthesis of aldehydes and ketone facilitated by a new solid-phase Weinreb amide. J. Org. Chem. 1999; 64: 1823-1830.
37. O'Donnell MJ, Drew MD, Pottorf RS, Scott WL. UPS on Weinreb resin: A facile solid-phase route to aldehyde and ketone derivatives of 'unnatural' amino acids and peptides. J. Comb. Chem. 2000; 2: 172-181.
38. Hall BJ, Sutherland JD. A practical method for the combinatorial synthesis of peptide aldehydes. Tetrahedron Lett. 1998; 39: 6593-6596.
39. Paris M, Heitz A, Guerlavais V, Gristau M, Fehrentz JA, Martinez J. Synthesis of peptide aldehydes on solid support using ozonolysis. Tetrahedron Lett. 1998; 39: 7287-7290.
40. Ede NJ, Eagle SN, Wickham G, Bray AM, Warne B, Shoemaker K, Rosenberg S. Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein. J. Peptide Sci. 2000: 6: 11-18.
41. Galéotti N, Giraud M, Jouin P. Solid phase synthesis of peptidyl aldehydes from C-terminal thiazolidinyl peptides. Lett. Pept. Sci. 1997; 4: 437-440.
42. Ramage R, Irving SL, McInnes C. Design of a versatile linker for solid phase peptide synthesis: Synthesis of C-terminal primary/secondary amides and hydrazides. Tetrahedron Lett. 1993; 34: 6599-6602.
43. Patterson JA, Ramage R. Solid phase synthesis of peptide C-terminal semicarbazones and aldehydes. Tetrahedron Lett. 1999: 40: 6121-6124.
44. Murphy AM, Dagnino R, Vallar PL, Trippe AL, Sherman SL, Lumpkin RH, Tamura SY, Webb TR. Automated synthesis of peptide C-terminal aldehydes. J. Am. Chem. Soc. 1992; 114: 3156-3157.
45. Yao W, Xu HY. Solid-phase synthesis of peptide aldehydes directly on acetal resin. Tetrahedron Lett. 2001; 42: 2549-2552.
46. Huwe CM, Kunzer H. A novel, thioacetal based linker for solid-phase synthesis. Tetrahedron Lett. 1999; 40: 683-686.
47. Yokum TS, Barany G. Preparation and applications of a thioacetal handle for solid-phase synthesis. In Peptides for the New Millennium: Proceedings of the Sixteenth American Peptide Symposium, Fields GB, Tam JP, Barany G (eds). Kluwer Academic: Dordrecht, The Netherlands, 2000; 179-180.
48. Blankespoor RL, DeVries T, Hansen E, Kallemeyn JM, Klooster AM, Mulder JA, Smart RP, Griend DAV. Photochemical synthesis of aldehydes in the solid phase. J. Org. Chem. 2002; 67: 2677-2681.
49. Jensen KJ, Alsina J, Songster MF, Vagner J, Albericio F, Barany G. Backbone amide linker (BAL) strategy for solid-phase synthesis of C-terminal-modified and cyclic peptides. J. Am. Chem. Soc. 1998; 120: 5441-5452.
50. α-9-fluorenylmethoxycarbonyl (Fmoc) solid-phase synthesis of unprotected peptide p-nitroanilides and thioesters. J. Org. Chem. 1999; 64: 8761-8769.
51. Alsina J, Yokum TS, Albericio, F, Barany G. A modified backbone amide linker (BAL) solid-phase peptide synthesis strategy accommodating prolyl, N-alkylamino acyl, or histidyl derivatives at the C-terminus. Tetrahedron Lett. 2000; 41: 7277-7280.
52. Felix AM, Heimer EP, Lambros TJ, Tzougraki C, Meienhofer J. Rapid removal of protecting groups from peptides by catalytic transfer hydrogenation with 1,4-cyclohexadiene. J. Org. Chem. 1978; 43: 4194-4196.
53. Mindt T, Michel U. Synthesis and evaluation of enantiomeric purity of protected α-amino and peptide aldehydes. Helv. Chim. Acta 1999; 82: 1960-1968.
54. Frommer W, Junge B, Müller L, Schmidt D, Truscheit E. New enzyme inhibitors from microorganisms. Planta Med. 1979; 35: 195-217.
55. Umezawa H, Aoyagi T. In Proteinase Inhibitors: Medical and Biological Aspects, Holzer H (ed.). Springer Verlag: Berlin, 1983; 3-15.
56. Schultz RM, Varma-Nelson P, Ortiz R, Kozlowsky KA, Orawsky AT, Pagast P, Frankfater A. Active and inactive forms of the transition-state analog protease inhibitor leupeptin: Explanation of the observed slow binding of leupeptin to cathepsin and papain. J. Biol. Chem. 1989; 264: 1497-1507.
57. McConnell RM, Barnes GE, Hoyng CF, Gunn JM. New leupeptin analogues: Synthesis and inhibition data. J. Med. Chem. 1990; 33: 86-93.
58. McConnell RM, York JL, Frizzel D, Ezell C. Inhibition studies of some serine and thiol proteinases by new leupeptin analogues. J. Med. Chem. 1993; 36: 1084-1089.
59. Schroder E, Phillips C, Garmen E, Harlos K, Crawford C. X-ray crystallographic structure of a papain-leupeptin complex. FEBS Lett. 1993; 315: 38-42.
60. Tatsuta K, Mikami N, Fujimoto K, Umezawa S, Umezawa H, Aoyagi T. The structure of chymostatin, a chymotrypsin inhibitor. J. Antibiot. 1973; 26: 625-646.
61. Bullock TL, Breddam K, Remington SJ. Peptide aldehyde complexes with wheat serine carboxypeptidase II: Implications for the catalytic mechanism and substrate specificity. J. Mol. Biol. 1996; 255: 714-725.
62. Suda H, Aoyagi T, Hamada M, Takeuchi T, Umezawa H. Antipain, a new proteinase inhibitor isolated from actinomycetes. J. Antibiot. 1972; 25: 263-266.
63. Umezawa S, Tatsuta K, Fujikane K, Tsujinaka T, Umezawa H, Naganawa H. Structure of antipain, a new Sakaguchi-positive product of Streptomyces. J. Antibiot. 1972; 25: 267-270.
64. Umezawa H. Structures and activities of protease inhibitors of microbial origin. Methods Enzymol. 1976; 45: 678-695.
65. Umezawa H, Aoyagi T, Okura A, Marishima H, Takeuchi T, Okami Y. Elastatinal, a new elastase inhibitor produced by actinomycetes. J. Antibiot. 1973; 26: 787-789.
66. Okura A, Morishima H, Takita T, Aoyagi T, Takeuchi T, Umezawa H. The structure of elastatinal, an elastase inhibitor of microbial origin. J. Antibiot. 1975; 28: 337-339.
67. Feinstein G, Malemuc CJ, Janoff A. The inhibition of human leukocyte elastase and chymotrypsin-like proteinase by elastatinal and chymostatin. Biochem. Biophys. Acta 1976: 429: 925-932.
68. Umezawa H, Aoyagi T. Activities of proteinase inhibitors of microbial origin. In Proteinases in Mammalian Cells and Tissues, Barrett A (ed.). Elsevier: Amsterdam, 1977; 637-662.
69. Zimmerman M, Ashe BM. Substrate specificity of the elastase and the chymotrypsin-like enzyme of the human granulocyte. Biochem. Biophys. Acta 1977; 480: 241-245.
70. Mehdi S, Angelastro MR, Wiseman JS, Bey P. Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain. Biochem. Biophys. Res. Commun. 1988; 157: 1117-1123.
71. Ariyoshi H, Shiba E, Kambayashi J, Sakon M, Tsujinaka T, Uemura Y, Mori T. Characteristics of various synthetic peptide calpain inhibitors and their application for the analysis of platelet reaction. Biochem. Int. 1991; 23: 1019-1033.
72. Page P, Bradley M. Solid-phase synthesis of tyrosine peptide aldehydes. Analogues of (S)-MAPI. J. Org. Chem. 1999; 64: 794-799.
73. Shepherd TA, Cox GA, McKinney E, Tang J, Wakulchik M, Zimmerman RE, Villarreal EC. Small peptidic aldehyde inhibitors of human rhinovirus 3C protease. Bioorg. Med. Chem. Lett. 1996; 6: 2893-2896.
74. Bajusz S, Szell E, Bagdy D, Barabas E, Horvath G, Dioszegi M, Fittler Z, Szabo G, Juhasz A, Tomori E, Szilagyi G. Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H. J. Med. Chem. 1990; 33: 1729-1735.
75. Chapman KT. Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzyme. Bioorg. Med. Chem. Lett. 1992; 2: 613-618.
76. Cousins GR, Friedrichs GS, Sudo Y, Rebello SS, Rote WE, Vlasuk GP, Nolan TG, Mendoza C, Lucchesi BR. Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog. Circulation 1996; 94: 1705-1712.
77. Rebello SS, Miller BV, Basler GC, Lucchesi BR. CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canin model of vascular Injury. Cardiovasc. Pharmacol. 1997; 29: 240-249.